Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Chloroquine Prevents Tumor Formation in Mouse Models

By Biotechdaily staff writers
Posted on 15 Jan 2008
Cancer researchers have found that the anti-malarial drug chloroquine prevented development of tumors in two different mouse models. More...


Investigators from St. Jude Children's Research Hospital (Memphis, TN, USA) studied the effect of chloroquine, which is known to mildly suppress the immune system, on tumor formation in a mouse model of Burkitt lymphoma and in ATM-deficient mice (a mouse model of ataxia telangiectasia).

They reported in the December 20, 2007, online edition of the Journal of Clinical Investigation that chloroquine effectively prevented cancer in the two mouse models. The mouse model of Burkitt lymphoma is a Myc-induced lymphoma, with Myc being protooncogene that is overexpressed in a wide range of human cancers. The drug also impaired spontaneous lymphoma development in the mouse model of ataxia telangiectasia.

Anti-cancer activity in both models was dependent on the activity of the p53 gene.
Chloroquine appeared to be effective in inducing the cellular features of autophagy (self-eating) and mediating its effects by inducing lysosomal stress and provoking p53-dependent cell death. The drug failed to inhibit tumor formation that was p53-independent.

The authors suggested that chloroquine or similar agents targeting lysosome-mediated degradation might be effective in cancer prevention.


Related Links:
St. Jude Children's Research Hospital

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Electrolyte Analyzer
BKE-B
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.